Increasing resilience of medical supply chains during the COVID-19 pandemic
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
Your browser may not be supported by this website. Please upgrade to the latest version provided by your browser vendor.
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
Novel plant-level data from Germany sheds light on the current status and the potential determinants of robot use in manufacturing factories.